Anna T Jonasova

2.0k citations
81 papers · 1.5k · 1 hit paper · h-index 21

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 56
    • Chronic Myeloid Leukemia Treatments 7
    • Multiple Myeloma Research and Treatments 6
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 9
    • Chronic Lymphocytic Leukemia Research 8
    • Hemoglobinopathies and Related Disorders 5

Anna T Jonasova

77 papers receiving 1.5k citations

Anna T Jonasova's Hit Papers

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial 2023 · 118 citations
1180+1+2Years since publication255075100

Peers

Anna T Jonasova
Comparison fields: 5 of 74
  • Hematology 1.1k
  • Genetics 424
  • Cancer Research 189
  • Emergency Medicine 81
  • Molecular Biology 541
Replace Christina Ganster with:
Christina Ganster Germany
Leonie Saft Sweden
Gunilla Walldin Sweden
François G. Kavelaars Netherlands
Annika Maria Dufour Germany
Bhumika J. Patel United States
Eva Hellström-Lindberg Sweden
Maria‐Cristina Sauerland Germany
Simona Conte Sweden
Jason H. Mendler United States
Anna T Jonasova relative to Christina Ganster Germany Christina Ganster's profile →
Citations per field
00.5×2×4×5.8×
Christina Ganster · 1×
Citations per year

Countries citing papers authored by Anna T Jonasova

Since Specialization
Citations

This map shows the geographic impact of Anna T Jonasova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna T Jonasova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna T Jonasova more than expected).

Fields of papers citing papers by Anna T Jonasova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna T Jonasova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna T Jonasova. The network helps show where Anna T Jonasova may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna T Jonasova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna T Jonasova Line = papers co-authored together Anna T Jonasova links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016191
2 1998186
3
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Hit paper breakdown →
2023118
4 202389
5 201182
6 200478
7 201463
8 202159
9 201645
10 202036
11 201133
12 202430
13 201429
14 201428
15 201626
16 201424
17 201323
18 201622
19 201421
20 202021

About Anna T Jonasova

Anna T Jonasova is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Immunology, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (56 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Epigenetics and DNA Methylation (6 papers), Multiple Myeloma Research and Treatments (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Hemoglobinopathies and Related Disorders (5 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (424 citations), Cancer Research (189 citations), Emergency Medicine (81 citations) and Molecular Biology (541 citations). Anna T Jonasova has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Jaroslav Čermák, Radana Neuwirtová, Magda Šišková, Monika Beličková, Michaela Dostálová Merkerová, Zdeněk Krejčík, Zuzana Zemanová, Kyra Michalova, Tomáš Stopka and Jǐŕı Kléma. Their work appears in journals such as Blood, Leukemia Research, British Journal of Haematology, European Journal Of Haematology and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact